Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4 GBX | -.--% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 1.799 |
Enterprise Value (EV) 1 | 1.155 |
P/E ratio | -5.54 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | - |
EV / FCF | -46,495,592 x |
FCF Yield | -0% |
Price to Book | 3.05 x |
Nbr of stocks (in thousands) | 17,132 |
Reference price 2 | 0.1050 |
Announcement Date | 5/13/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net sales | - | - |
EBITDA | - | - |
EBIT 1 | -0.061 | -0.0893 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | -0.061 | -0.194 |
Net income 1 | -0.061 | -0.194 |
Net margin | - | - |
EPS 2 | -0.006362 | -0.0190 |
Free Cash Flow | - | -0.0248 |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 11/21/22 | 5/13/23 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 0.2 | 0.64 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -0.02 |
ROE (net income / shareholders' equity) | - | -51.1% |
ROA (Net income/ Total Assets) | - | -10.8% |
Assets 1 | - | 1.793 |
Book Value Per Share 2 | 0.0200 | 0.0300 |
Cash Flow per Share 2 | 0.0200 | 0.0400 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 11/21/22 | 5/13/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.13M | |
+162.97% | 8.13B | |
+2.33% | 984M | |
+41.91% | 883M | |
+20.28% | 786M | |
+2.20% | 667M | |
+5.03% | 631M | |
-.--% | 600M | |
+8.61% | 528M | |
-.--% | 500M |
- Stock Market
- Equities
- MCI Stock
- Financials Medcaw Investments Plc